Exact Sciences Corp (EXAS)
SERVICES-MEDICAL LABORATORIES
- Headquarters
- United States
- Employees
- 7,200
- Market Cap
- $20.0B
About Exact Sciences Corp
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
SentiSense also tracks daily options readings for Exact Sciences Corp: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Exact Sciences Corp stock analysis, sentiment tracking, and market intelligence on SentiSense.